Login to Your Account



Pharma: Other News To Note


Thursday, November 14, 2013
• Boehringer Ingelheim GmbH, of Ingelheim, Germany, said it submitted applications to extend the indication for the use of tiotropium (Spiriva) Respimat to the treatment of asthma in adults.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription